Ebpay生命医药出版社


Ebpay生命

102445

论文已发表

提 交 论 文


注册即可获取Ebpay生命的最新动态

注 册



IF 收录期刊



  • 3.3 Breast Cancer (Dove Med Press)
  • 3.4 Clin Epidemiol
  • 2.5 Cancer Manag Res
  • 2.9 Infect Drug Resist
  • 3.5 Clin Interv Aging
  • 4.7 Drug Des Dev Ther
  • 2.7 Int J Chronic Obstr
  • 6.6 Int J Nanomed
  • 2.5 Int J Women's Health
  • 2.5 Neuropsych Dis Treat
  • 2.7 OncoTargets Ther
  • 2.0 Patient Prefer Adher
  • 2.3 Ther Clin Risk Manag
  • 2.5 J Pain Res
  • 2.8 Diabet Metab Synd Ob
  • 2.8 Psychol Res Behav Ma
  • 3.0 Nat Sci Sleep
  • 1.8 Pharmgenomics Pers Med
  • 2.7 Risk Manag Healthc Policy
  • 4.2 J Inflamm Res
  • 2.1 Int J Gen Med
  • 4.2 J Hepatocell Carcinoma
  • 3.7 J Asthma Allergy
  • 1.9 Clin Cosmet Investig Dermatol
  • 2.7 J Multidiscip Healthc



更多详情 >>





已发表论文

葡萄糖代谢状态转变对从 A 期进展至 C 期心力衰竭的影响

 

Authors Yin M , Xu X, Li J, Sun Y, Zhen Y, Wu S , Fang H

Received 3 March 2025

Accepted for publication 15 May 2025

Published 22 May 2025 Volume 2025:18 Pages 1683—1693

DOI http://doi.org/10.2147/DMSO.S525408

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Dr Hillary Keenan

Mingjie Yin,1 Xiaoyu Xu,2 Jie Li,1 Yanan Sun,3 Yanfeng Zhen,3 Shouling Wu,4 Hui Fang1,3 

1Department of Internal Medicine, Hebei Medical University, Shijiazhuang, Hebei, People’s Republic of China; 2Training Base, Tangshan Gongren Hospital, Tangshan, Hebei, People’s Republic of China; 3Second Department of Endocrinology and Metabolism, Tangshan Gongren Hospital, Tangshan, Hebei, People’s Republic of China; 4Department of Cardiology, Kailuan General Hospital, Tangshan, Hebei, People’s Republic of China

Correspondence: Hui Fang, Department of Internal Medicine, Hebei Medical University, 361 Zhongshan East Road, Shijiazhuang, Hebei, 050000, People’s Republic of China, Tel +8613831581838, Email fanghui2818@126.com

Background: Heart failure (HF) constitutes a significant global health challenge. The interplay between the dynamics of glucose metabolic status transitions and the progression of HF has been minimally explored.
Objective: We assessed the impact of shifts in glucose metabolic states on the progression from stage A to stage C HF.
Methods: The Kailuan Study is a large-scale prospective cohort study. Based on data from the Kailuan Study, 41,110 stage A HF patients were included and stratified into 6 groups based on alterations in glucose metabolic status: stable normoglycemic, stable pre-diabetes, diabetes, normoglycemic progressing to pre-diabetes, pre-diabetes back to normoglycemic, and normoglycemic/pre-diabetes progressing to diabetes. Utilizing the Cox proportional hazards regression model, we calculated the hazard ratios (HR) and 95% confidence intervals (CI) associated with the transition to stage C HF among patients with stage A HF with different glucose metabolic state transitions.
Results: Our findings indicated a notably elevated risk for the progression to stage C HF within the diabetic group relative to the stable normoglycemic group (HR, 1.87; 95% CI, 1.66 to 2.10). Additionally, an augmented risk for the progression to stage C HF was observed in the normoglycemic/pre-diabetic to diabetic group (HR, 1.38; 95% CI, 1.15 to 1.65).
Conclusion: Both diabetes and normoglycemic/pre-diabetes progressing to diabetes are associated with heightened risks of progressing from stage A to stage C HF. Conversely, the re-establishment of normoglycemic in pre-diabetes is associated with preventing HF progression.

Keywords: glucose metabolic state, diabetes, pre-diabetes, stage A heart failure, stage C heart failure

Download Article[PDF]